Deep Vein Thrombosis (DVT)
Two-level Wells Score
Clinical probability simplified score
- DVT likely: 2 points or more
- DVT unlikely: 1 point or less
If a DVT is 'likely' (2 points or more)
- a proximal leg vein ultrasound scan should be carried out within 4 hours
- if the result is positive then a diagnosis of DVT is made and anticoagulant treatment should start
- if the result is negative a D-dimer test should be arranged. A negative scan and negative D-dimer makes the diagnosis unlikely and alternative diagnoses should be considered
- if a proximal leg vein ultrasound scan cannot be carried out within 4 hours a D-dimer test should be performed and interim therapeutic anticoagulation administered whilst waiting for the proximal leg vein ultrasound scan (which should be performed within 24 hours)
- interim therapeutic anticoagulation used to mean giving low-molecular weight heparin
- NICE updated their guidance in 2020. They now recommend using an anticoagulant that can be continued if the result is positive.
- this means normally a direct oral anticoagulant (DOAC) such as apixaban or rivaroxaban
- if the scan is negative but the D-dimer is positive:
- stop interim therapeutic anticoagulation
- offer a repeat proximal leg vein ultrasound scan 6 to 8 days later
If a DVT is 'unlikely' (1 point or less)
- perform a D-dimer test
- this should be done within 4 hours. If not, interim therapeutic anticoagulation should be given until the result is available
- if the result is negative then DVT is unlikely and alternative diagnoses should be considered
- if the result is positive then a proximal leg vein ultrasound scan should be carried out within 4 hours
- if a proximal leg vein ultrasound scan cannot be carried out within 4 hours interim therapeutic anticoagulation should be administered whilst waiting for the proximal leg vein ultrasound scan (which should be performed within 24 hours)
D-dimer tests
- NICE recommend either a point-of-care (finger prick) or laboratory-based test
- age-adjusted cut-offs should be used for patients > 50 years old

Management
Choice of anticoagulant
- the big change in the 2020 guidelines was the increased use of DOACs
- apixaban or rivaroxaban (both DOACs) should be offered first-line following the diagnosis of a DVT
- instead of using low-molecular weight heparin (LMWH) until the diagnosis is confirmed, NICE now advocate using a DOAC once a diagnosis is suspected, with this continued if the diagnosis is confirmed
- if neither apixaban or rivaroxaban are suitable then either LMWH followed by dabigatran or edoxaban OR LMWH followed by a vitamin K antagonist (VKA, i.e. warfarin)